Recent Research Grants

  • High intensity interval training and nicotinamide riboside treatment to enhance functional capacity and reduce frailty during aging. Kenneth Seldeen (Co-Investigator). Veterans Affairs. $645,000. 7/1/2019-6/1/2023.
  • Community-Based Participatory Research for Reducing Medication Harm among Retirees. Christopher Daly (Co-Investigator), David Jacobs (Co-Investigator), Scott Monte (Co-Investigator), Ranjit Singh (Co-Principal Investigator), Bruce Troen (Co-Investigator), Robert Wahler (Co-Principal Investigator). Retirement Research Foundation. $200,000. 5/1/2019-4/1/2021.
  • Enhancing Geroscience Faculty Development and Scholarship in Order to Minimize Frailty and Maximize Healthspan. Bruce Troen (Principal Investigator). NIH / National Institute of Aging. $750,000. 5/1/2019-5/1/2024.
  • VA CDA-2, The Functional Role of Exosomes in Stem Cell-Mediated Cardiac Repair, VA. Jennifer Lang (Principal Investigator). Veteran‘s Administration. $1,389,635. 10/1/2018-9/1/2023.
  • Enhancing functional capacity in older adults with short session high intensity interval training. Kenneth Seldeen (Co-Investigator). Veterans Affairs. $200,000. 10/1/2018-9/1/2020.
  • Post-Transcriptional Control of Aging-Associated Inflammation and Bone Homeostasis. Bruce Troen (Co-Investigator). NIH - National Institute of Dental and Craniofacial Research. $1,187,500. 10/1/2018-9/1/2023.
  • Post-Transcriptional Control of Aging-Associated Inflammation and Bone Homeostasis. Keith Kirkwood (Principal Investigator), Kenneth Seldeen (Co-Investigator), Bruce Troen (Co-Investigator). NIH NIDCR. $1,250,000. 10/1/2018-9/1/2023.
  • Alzheimer’s and related dementias Care improvement Through Data Science Education (ACT-DSE): Custom training for Research. Bruce Troen (Co-Investigator). National Institutes of Health. $270,000. 9/1/2018-6/1/2020.
  • DHODH Inhibitors: A Potential New Class of Antimicrobials for Treatment of the Drug Resistant Gram-Negative Bacillus Acinetobacter baumannii. Thomas Russo (Co-Principal Investigator). NIH/NIAID. $981,697. 8/1/2018-8/1/2020.
  • Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeutic nanoparticles for TB. Jessica Reynolds (Principal Investigator). NIAID. $2,197,275. 8/1/2018-7/1/2023.
  • Activating Adrenergic Receptors to Suppress the Anti-graft Immune Response and Improve Survival of Composite Tissue Allografts. Umesh Sharma (Co-Investigator). National Institutes of Health/SBIB. $356,467. 7/1/2018-6/1/2020.
  • NIH R01. Jessy Alexander (Principal Investigator). National Institute of Health. $717,750. 7/1/2018-7/1/2021.
  • UB CAT: Circuit Clinical Data Collection and Analytics Systems, phase II. Manoj Mammen (Principal Investigator). UB CAT. $197,563. 7/1/2018-6/1/2019.
  • Collaborative Drug Safety Management with Frail Elders & Caregivers for Successful Aging. Scott Monte (Co-Investigator), Ranjit Singh (Principal Investigator), Bruce Troen (Co-Investigator), Robert Wahler (Co-Investigator). University at Buffalo, Innovative Micro-Programs Accelerating Collaboration in Themes (IMPACT). $35,000. 6/1/2018-6/1/2019.
  • Focus on Afib. Jeffrey Lackner (Principal Investigator), Brian Quigley (Co-Investigator). Independent Health. $74,867. 5/1/2018-4/1/2019.
  • CTSI Pilot Study: Linking New York State Databases to Identify Risk Factors and Gaps in care for rural and urban health disparities in lung cancer. Manoj Mammen (Co-Investigator). CTSI. $50,000. 5/1/2018-4/1/2019.
  • Liposomal Delivery of a Novel Peptide N-Acetyl-Ser-Asp-Lys-Pro to Inhibit Cancer Radiotherapy-Induced Cardiac Damage. Umesh Sharma (Co-Investigator). National Institutes of Health/NHLBI. $462,000. 4/1/2018-2/1/2020.
  • Investigation of anti-LTa in Sjögren’s syndrome in IL14aTG mice. Julian Ambrus, Jr. (Co-Principal Investigator). Genentech. 1/1/2018-12/1/2020.
  • Cytokines in Early Sjogren's Syyndrome. Julian Ambrus, Jr. (Co-Principal Investigator). Amgen. 1/1/2018-12/1/2020.
  • American Hearing Research Foundation. Jessy Alexander (Principal Investigator). American Hearing Research Foundation. $20,000. 1/1/2018-12/1/2018.